| Pharmaceutical active ingredients: |
| Hydroxyurea |
| Available forms, composition and doses of Droxia: |
| Capsules; Oral; Hydroxyurea 200 mgCapsules; Oral; Hydroxyurea 300 mgCapsules; Oral; Hydroxyurea 400 mgCapsules; Oral; Hydroxyurea 500 mg |
| Droxia medical category: |
| Human:Antineoplastic agentsCytotoxic chemotherapy |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| L01XX05 - Hydroxycarbamide |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Bayer Schering PharmaBristol-Myers Squibb |
| Related documents and information about Droxia: |
| Droxia prescribing information (PDF) |